U.S., March 31 -- ClinicalTrials.gov registry received information related to the study (NCT07499804) titled 'Effect of Tadalafil on Endometrial Thickness and Frozen Embryo Transfer Outcomes' on March 19.
Brief Summary: investigate the effect of different vasodilators as Tadalafil in women with unexplained infertility using IVF
Study Start Date: Oct. 01, 2023
Study Type: INTERVENTIONAL
Condition:
IVF
Infertility, Female
Intervention:
DRUG: Tadalafil 5mg
phosphodiesterase type 5 (PDE-5) inhibitor
DRUG: estradiol valerate 2 mg
estradiol valerate 2 mg. in form of (Cycloprogynova(R) Bayer Shering Pharma) white pills starting dose is one pill T.I.D may be increased to two pills T.I.D according to endometrial thickness in day 9 measured...